A review of studies on the mode of action of clofibrate and betabenzalbutyrate
- 1 February 1972
- Vol. 7 (2), 106-109
- https://doi.org/10.1007/bf02532596
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Inhibition of hepatic triglyceride formation by clofibrateJCI Insight, 1971
- Effects of diet on hepatic triglyceride synthesisJCI Insight, 1968
- Effect of CPIB ester on plasma free fatty acid levels in manMetabolism, 1966
- An enzymatic fluorometric micromethod for the determination of glycerolClinica Chimica Acta; International Journal of Clinical Chemistry, 1966
- Studies with ethyl chlorophenoxyisobutyrate (clofibrate)Metabolism, 1965
- Effect of p-chlorophenoxyisobutyric acid, ethyl p-chlorophenoxyisobutyrate, and Atromid on the synthesis of nonsaponifiable material and cholesterol in the bovine aortaBiochemical Pharmacology, 1965
- Reduction of serum triglycerides and cholesterol by ethyl p-chlorophenoxyisobutyrate (CPIB)The American Journal of Cardiology, 1965
- EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATEThe Lancet, 1962
- REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONEThe Lancet, 1962
- Ptyctodontid Fishes and the Ancestry of HolocephaliNature, 1962